What is the expected growth forecast for the PCR and Real-time PCR Molecular Diagnostics market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033.

What are the key drivers of the PCR and Real-time PCR Molecular Diagnostics market?

Increasing demand for molecular diagnostics and technological advancements drive the market.

What are the major challenges facing the PCR and Real-time PCR Molecular Diagnostics market?

High equipment costs and regulatory hurdles hinder market growth.

Which regions are leading the PCR and Real-time PCR Molecular Diagnostics market?

North America and Europe dominate the market due to advanced healthcare infrastructure.

Who are the top companies in the PCR and Real-time PCR Molecular Diagnostics market?

Major players include Roche, Abbott, and Bio-Rad, offering innovative diagnostic solutions.

What future opportunities exist in the PCR and Real-time PCR Molecular Diagnostics market?

Emerging economies and point-of-care diagnostics present significant future outlook opportunities.

How does technology impact the PCR and Real-time PCR Molecular Diagnostics market?

Advances in PCR technology improve diagnostic accuracy and efficiency, driving market growth.

What is the regulatory landscape for the PCR and Real-time PCR Molecular Diagnostics market?

Stringent regulations and standards ensure diagnostic quality and safety, shaping market trends.

PCR and Real-time PCR Molecular Diagnostics Trends, Opportunities & Forecast 2033

PCR and Real-time PCR Molecular Diagnostics by Application (Infectious Diseases Testing, Oncology Testing, Genetic Testing, Others), by Types (Instruments, Reagents, Consumables), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 102

Forecast Period: 2026 - 2033

Market Size: $12.6 million

CAGR: 8.9%

Historical Range: 2020 - 2025

Dec 22, 2025Updated: Jun 8, 2026

Pages: 102

Forecast Period: 2026 - 2033

Market Size: $12.6 million

CAGR: 8.9%

Historical Range: 2020 - 2025

Loading report content...

Loading report...

PCR and Real-time PCR Molecular Diagnostics Market Size | CAGR 8.9 Forecast 2033

PCR and Real-time PCR Molecular Diagnostics Trends, Opportunities & Forecast 2033

🏭 Healthcare🌍 Global

Pages: 102

Forecast Period: 2026 - 2033

Market Size: $12.6 million

CAGR: 8.9%

Historical Range: 2020 - 2025

Dec 22, 2025Updated: Jun 8, 2026

Pages: 102

Forecast Period: 2026 - 2033

Market Size: $12.6 million

CAGR: 8.9%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

PCR and Real-time PCR Molecular Diagnostics Market Overview

The PCR and Real-time PCR Molecular Diagnostics market is a crucial segment of the healthcare industry, playing a vital role in the diagnosis and monitoring of various diseases. As the market continues to evolve, it is essential to understand the current PCR and Real-time PCR Molecular Diagnostics market size, which is approximately $14.4 billion, and its growth outlook, with a projected market forecast of $24.5 billion by 2033. The industry expansion is driven by the increasing demand for molecular diagnostics, advancements in technology, and the rising prevalence of infectious diseases. The scope of this market encompasses various types of PCR and real-time PCR technologies, including quantitative PCR, reverse transcription PCR, and digital PCR, which are used in applications such as infectious disease diagnosis, cancer research, and genetic testing.

Loading chart…

The PCR and Real-time PCR Molecular Diagnostics market is expected to grow at a CAGR of 8.5% during the forecast period, driven by macro drivers such as the increasing demand for molecular diagnostics, advancements in technology, and the rising prevalence of infectious diseases. Key forces shaping the industry include technology shifts, such as the development of portable PCR devices, regulations, such as the increasing need for standardization, and consumer behavior, such as the growing awareness of molecular diagnostics. The largest region in the PCR and Real-time PCR Molecular Diagnostics market is North America, while the fastest-growing region is Asia-Pacific. The market is expected to be driven by the increasing demand for molecular diagnostics in emerging economies, such as China and India.

Report Overview

Report Attribute	Details
Market size value in 2025	12.60 million
Revenue forecast in 2033	24.92 million
Growth rate	CAGR of 8.9% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Abbott Laboratories; bioMérieux SA; Danaher Corporation; Bio-Rad Laboratories; QIAGEN N.V; F. Hoffmann-La Roche Ltd.; Genomic Health; Grifols, S.A.; Thermo Fisher Scientific Inc.; Seegene Inc.; Hologic Inc.
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The PCR and Real-time PCR Molecular Diagnostics market is poised for significant growth, driven by increasing demand for precise and rapid diagnostic testing. This section provides an in-depth analysis of the market dynamics, including growth drivers, restraints, opportunities, and challenges that are expected to influence the PCR and Real-time PCR Molecular Diagnostics market size and growth forecast.

Growth Drivers2 items

Advancements in technology, such as the development of portable and point-of-care PCR devices, are expanding the reach of molecular diagnostics and driving growth in the PCR and Real-time PCR Molecular Diagnostics market.

Increasing prevalence of infectious diseases, such as COVID-19, is fueling the demand for rapid and accurate diagnostic testing, thereby contributing to the growth of the PCR and Real-time PCR Molecular Diagnostics market.

Restraints2 items

High costs associated with PCR and real-time PCR equipment, as well as the need for skilled personnel to operate these devices, are limiting the adoption of molecular diagnostics in resource-constrained settings.

Stringent regulatory requirements and the need for extensive validation and verification of PCR and real-time PCR tests are slowing down the development and commercialization of new products in the PCR and Real-time PCR Molecular Diagnostics market.

Opportunities2 items

Emerging markets, such as Asia-Pacific and Latin America, offer significant growth opportunities for the PCR and Real-time PCR Molecular Diagnostics market, driven by increasing demand for molecular diagnostics and improving healthcare infrastructure.

The growing trend of personalized medicine is expected to drive the adoption of PCR and real-time PCR-based molecular diagnostics, enabling targeted and effective treatment of diseases.

Challenges2 items

The PCR and Real-time PCR Molecular Diagnostics market is highly competitive, with several established players competing for market share, making it challenging for new entrants to establish themselves.

The need for ongoing innovation and investment in research and development to stay ahead of the competition and address emerging trends, such as point-of-care testing and artificial intelligence, poses a significant challenge for companies operating in the PCR and Real-time PCR Molecular Diagnostics market.

Market Segmentation

Loading chart…

The PCR and Real-time PCR Molecular Diagnostics segmentation by application includes infectious disease testing, oncology testing, genetic testing, and other applications. Each of these segments contributes to the overall market size, with infectious disease testing holding the largest share due to the increasing prevalence of infectious diseases and the need for rapid and accurate diagnostic testing. The market taxonomy for PCR and Real-time PCR Molecular Diagnostics is complex, with various sub-segments within each application category, such as viral disease testing and bacterial disease testing within infectious disease testing.

The types segment in the PCR and Real-time PCR Molecular Diagnostics market includes conventional PCR, real-time PCR, and digital PCR. These types are further sub-divided into qualitative PCR and quantitative PCR. Conventional PCR is widely used for various applications, while real-time PCR is preferred for its high sensitivity and specificity. The market size for each type varies, with real-time PCR dominating the market due to its accuracy and speed. Understanding the PCR and Real-time PCR Molecular Diagnostics segmentation by type is crucial for industry players to develop targeted strategies and products.

PCR and Real-time PCR Molecular Diagnostics Segmentation Breakdown9 items

Application

Infectious Diseases Testing

Oncology Testing

Genetic Testing

Others

Types

Instruments

Reagents

Consumables

Regional Insights

Loading chart…

The PCR and Real-time PCR Molecular Diagnostics market growth is expected to vary across regions, with North America being the largest region, accounting for approximately 40% of the market share. The Asia Pacific region is anticipated to be the fastest-growing region, driven by increasing adoption of molecular diagnostics, investments in healthcare infrastructure, and a growing ecosystem maturity.

Key drivers for North America include a mature ecosystem, high adoption rates, and significant investments in research and development. In Europe, drivers include favorable policies, a strong infrastructure, and a high demand for molecular diagnostics. The Asia Pacific region is driven by a large and growing demographics, increasing adoption of molecular diagnostics, and significant investments in healthcare. Latin America and Middle East & Africa are driven by growing demand for molecular diagnostics, increasing infrastructure development, and favorable policies.

The regional forecast indicates that Asia Pacific will experience the highest growth rate, driven by the factors mentioned earlier. North America and Europe are expected to maintain their market share, while Latin America and Middle East & Africa will experience moderate growth. The PCR and Real-time PCR Molecular Diagnostics market growth will be influenced by these regional trends, with each region presenting unique opportunities and challenges.

Competitive Landscape

The PCR and Real-time PCR Molecular Diagnostics competitive landscape is moderately consolidated, driven by a mix of global players and local companies. Key competitive levers include pricing, distribution, product innovation, certifications, and regulatory approvals. The market is characterized by high competition, with companies focusing on differentiating themselves through innovative products and services. Understanding the PCR and Real-time PCR Molecular Diagnostics competitive landscape is crucial for companies to develop effective strategies and stay ahead in the market.

Companies in the market are adopting various strategies to differentiate themselves, including M&A, partnerships, product launches, expansion, R&D, and localization. However, they face challenges such as margin pressure, compliance costs, and commoditization. To stay competitive, companies must focus on innovative technologies, strong service models, and robust channel strength. The following companies are implementing different strategies to stay ahead in the market:

Abbott Laboratories: regional expansion

bioMérieux SA: innovation pipeline

Danaher Corporation: vertical integration

Bio-Rad Laboratories: premium pricing

QIAGEN N.V: OEM tie-ups

F. Hoffmann-La Roche Ltd.: local manufacturing

Key PCR and Real-time PCR Molecular Diagnostics Companies11 items

Abbott Laboratories

bioMérieux SA

Danaher Corporation

Bio-Rad Laboratories

QIAGEN N.V

F. Hoffmann-La Roche Ltd.

Genomic Health

Grifols, S.A.

Thermo Fisher Scientific Inc.

Seegene Inc.

Hologic Inc.

Market Ecosystem

The PCR and Real-time PCR Molecular Diagnostics ecosystem spans across upstream, midstream, and downstream segments, encompassing technology providers, integrators, channels, and end users. Value is created and captured through the development and supply of molecular diagnostic technologies, integration with existing healthcare systems, and delivery to end users, including hospitals, laboratories, and research institutions. The ecosystem is characterized by a complex interplay of participants, each playing a distinct role in the creation and delivery of molecular diagnostic solutions.

Raw material/component suppliers — provide essential components

OEMs / manufacturers — design and manufacture diagnostic equipment

Technology providers — develop and license molecular diagnostic technologies

System integrators / EPCs — integrate diagnostic systems with existing infrastructure

Distributors / channel partners — deliver diagnostic solutions to end users

Regulators/standards bodies — establish and enforce diagnostic standards and regulations

End users / buyers — utilize molecular diagnostic solutions for patient care and research

The flow of value in the PCR and Real-time PCR Molecular Diagnostics ecosystem is influenced by control points, such as regulatory approvals and standards, which can create bottlenecks and impact adoption. Dependency risks, including input constraints and interoperability requirements, can also affect the ecosystem. Furthermore, switching costs and partnership requirements may vary by region, with different regions having distinct regulatory frameworks and market characteristics, highlighting the need for a thorough value chain analysis to navigate the PCR and Real-time PCR Molecular Diagnostics ecosystem effectively.

Recent Industry Insights

The PCR and Real-time PCR Molecular Diagnostics industry trends have witnessed significant developments over the last 12-18 months. Notable partnerships have been formed, such as collaborations between leading diagnostic companies and research institutions, to advance the development of innovative PCR-based diagnostic solutions. Furthermore, the industry has seen a surge in mergers & acquisitions, with major players expanding their product portfolios and strengthening their market presence. Recent product launches have also focused on enhancing the sensitivity, specificity, and speed of PCR-based diagnostic tests.

Additionally, regulatory changes have been implemented to ensure the safe and effective use of PCR-based diagnostic tests. There has been a shift in consumer or enterprise trends towards the adoption of point-of-care diagnostic solutions, driving the demand for portable and user-friendly PCR devices. The industry has also seen significant funding rounds or expansions, with investors backing companies that are developing cutting-edge PCR technologies. These developments are expected to shape the future of the PCR and Real-time PCR Molecular Diagnostics industry.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the PCR and Real-time PCR Molecular Diagnostics market outlook. The market exhibits high attractiveness due to increasing demand for molecular diagnostics, driven by the growing need for accurate and rapid testing. The competitive intensity is moderate, with key players investing heavily in research and development to stay ahead. The long-term outlook is positive, with the market expected to grow significantly over the next five years.

The innovation landscape is dynamic, with advancements in technology and the introduction of new products. However, the demand-supply balance is a key risk factor, as supply chain disruptions can impact the availability of critical components. Overall, the market offers significant opportunities for growth, but players must be aware of the potential risks and challenges to succeed in this competitive environment.

11 items

1. Executive Summary

2. PCR and Real-time PCR Molecular Diagnostics Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global PCR and Real-time PCR Molecular Diagnostics Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global PCR and Real-time PCR Molecular Diagnostics Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Infectious Diseases Testing

6.1.2. Oncology Testing

6.1.3. Genetic Testing

6.1.4. Others

6.2. Global PCR and Real-time PCR Molecular Diagnostics Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Instruments

6.2.2. Reagents

6.2.3. Consumables

6.3. Global PCR and Real-time PCR Molecular Diagnostics Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global PCR and Real-time PCR Molecular Diagnostics Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global PCR and Real-time PCR Molecular Diagnostics Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global PCR and Real-time PCR Molecular Diagnostics Market Competition by Key Manufacturers

8.1. Global PCR and Real-time PCR Molecular Diagnostics Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global PCR and Real-time PCR Molecular Diagnostics: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Abbott Laboratories

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. bioMérieux SA

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Danaher Corporation

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Bio-Rad Laboratories

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. QIAGEN N.V

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. F. Hoffmann-La Roche Ltd.

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Genomic Health

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Grifols, S.A.

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Thermo Fisher Scientific Inc.

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Seegene Inc.

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. Hologic Inc.

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global PCR and Real-time PCR Molecular Diagnostics Market

Figure 4: Global PCR and Real-time PCR Molecular Diagnostics Market: Drivers

Figure 5: Global PCR and Real-time PCR Molecular Diagnostics Market: Challenges

Figure 6: Global PCR and Real-time PCR Molecular Diagnostics Market: Trends

Figure 7: Global PCR and Real-time PCR Molecular Diagnostics Market: Opportunity

Figure 8: Global PCR and Real-time PCR Molecular Diagnostics Market: Restraint

Figure 9: Global PCR and Real-time PCR Molecular Diagnostics Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global PCR and Real-time PCR Molecular Diagnostics Market Value (USD Million) By Region

Figure 15: Global PCR and Real-time PCR Molecular Diagnostics Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global PCR and Real-time PCR Molecular Diagnostics Market Value (USD Million) By Region

Figure 23: Global PCR and Real-time PCR Molecular Diagnostics Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

75 items

Table 1: Market Segmentation Analysis

Table 2: Global PCR and Real-time PCR Molecular Diagnostics Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global PCR and Real-time PCR Molecular Diagnostics Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global PCR and Real-time PCR Molecular Diagnostics Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global PCR and Real-time PCR Molecular Diagnostics Market Value (USD Million) By Region

Table 10: Global PCR and Real-time PCR Molecular Diagnostics Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global PCR and Real-time PCR Molecular Diagnostics Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global PCR and Real-time PCR Molecular Diagnostics Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global PCR and Real-time PCR Molecular Diagnostics Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Abbott Laboratories Basic Information And Sales Area

Table 31: Abbott Laboratories. Products Portfolio

Table 32: bioMérieux SA Basic Information And Sales Area

Table 33: bioMérieux SA. Products Portfolio

Table 34: Danaher Corporation Basic Information And Sales Area

Table 35: Danaher Corporation. Products Portfolio

Table 36: Bio-Rad Laboratories Basic Information And Sales Area

Table 37: Bio-Rad Laboratories. Products Portfolio

Table 38: QIAGEN N.V Basic Information And Sales Area

Table 39: QIAGEN N.V. Products Portfolio

Table 40: F. Hoffmann-La Roche Ltd. Basic Information And Sales Area

Table 41: F. Hoffmann-La Roche Ltd.. Products Portfolio

Table 42: Genomic Health Basic Information And Sales Area

Table 43: Genomic Health. Products Portfolio

Table 44: Grifols, S.A. Basic Information And Sales Area

Table 45: Grifols, S.A.. Products Portfolio

Table 46: Thermo Fisher Scientific Inc. Basic Information And Sales Area

Table 47: Thermo Fisher Scientific Inc.. Products Portfolio

Table 48: Seegene Inc. Basic Information And Sales Area

Table 49: Seegene Inc.. Products Portfolio

Table 50: Hologic Inc. Basic Information And Sales Area

Table 51: Hologic Inc.. Products Portfolio

Table 52: Global Market Value (USD Million) (2025-2032) By Application

Table 53: Global Market Share (%) By Application (2032)

Table 54: Global Market Value (USD Million) (2025-2032) By Types

Table 55: Global Market Share (%) By Types (2032)

Table 56: Global PCR and Real-time PCR Molecular Diagnostics Market Value (USD Million) By Region

Table 57: Global PCR and Real-time PCR Molecular Diagnostics Market Share (%) By Region (2025-2032)

Table 58: North America Market Value (USD Million) (2025-2032) By Country

Table 59: North America Market Value (USD Million) (2025-2032) By Application

Table 60: North America Market Value (USD Million) (2025-2032) By Types

Table 61: Europe Market Value (USD Million) (2025-2032) By Country

Table 62: Europe Market Value (USD Million) (2025-2032) By Application

Table 63: Europe Market Value (USD Million) (2025-2032) By Types

Table 64: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 65: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 66: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 67: South America Market Value (USD Million) (2025-2032) By Country

Table 68: South America Market Value (USD Million) (2025-2032) By Application

Table 69: South America Market Value (USD Million) (2025-2032) By Types

Table 70: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 71: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 72: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 73: Research Programs/Design For This Report

Table 74: Key Data Information From Secondary Sources

Table 75: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

PCR and Real-time PCR Molecular Diagnostics Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	12.60 million
Revenue forecast in 2033	24.92 million
Growth rate	CAGR of 8.9% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Abbott Laboratories; bioMérieux SA; Danaher Corporation; Bio-Rad Laboratories; QIAGEN N.V; F. Hoffmann-La Roche Ltd.; Genomic Health; Grifols, S.A.; Thermo Fisher Scientific Inc.; Seegene Inc.; Hologic Inc.
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options